Cost-containment strategies successful in Taiwan

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1554, 2006-01, pp. : 3-3

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cost-Containment as Part of Pharmaceutical Policy

By Almarsdóttir Anna Traulsen Janine

Pharmacy World and Science, Vol. 27, Iss. 3, 2005-06 ,pp. : 144-148

Springer Publishing Company

Access to resources Recommend Favorite

Impacts of Cost Containment Strategies on Pharmaceutical Expenditures of the National Health Insurance in Taiwan, 1996-2003

By Lee Yue-Chune

PharmacoEconomics, Vol. 24, Iss. 9, 2006-01 ,pp. : 891-902

Adis International

Access to resources Recommend Favorite

Drug price cuts have been made a priority for the French government's pharmaceutical cost-containment policy

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 340, 2001-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite

Conclusions about Canadian drug cost containment `unwarranted'

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 334, 2001-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Drug expenditure the key to cost containment?

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 318, 2001-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite